NewGenIvf Group Limited (NIVFW)

NewGenIvf Group Limited (NIVFW) — VMCI valuation read

NewGenIvf Group Limited sits at VMCI 45/100, with the Healthcare sector median at 50. That 5-point spread is the first thing to note on NIVFW: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on NIVFW are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on NIVFW: NIVFW trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of 3.0x is the rate-sensitivity line to watch, anchoring the bear scenario on a measurable balance-sheet metric.

NIVFW fell 3.4% over the trailing 7 days, with a +6.9% read on a 30-day basis.